Verify regulatory 503A compliance and calculate out-of-pocket savings for compounded Tirzepatide & Semaglutide in Texas compared to retail commercial list prices ($1050/mo).
Status: Broadly Available via 503A & 503B Compounding Facilities
Texas has an established network of in-state 503A compounding pharmacies and allows licensed medical providers to prescribe customized peptide compounds via synchronous and asynchronous telehealth platforms.
Statutory Citation: Tex. Occ. Code § 562.151 & Texas State Board of Pharmacy Rules
Texas has an established network of in-state 503A compounding pharmacies and allows licensed medical providers to prescribe customized peptide compounds via synchronous and asynchronous telehealth platforms.
Yes. Texas regulations allow licensed physicians and nurse practitioners to prescribe compounded medications through compliant telehealth consultations.
Browse deep clinical analysis and metabolic decision models on Groundwork.